Antara Capital LP Tg Therapeutics, Inc. Call Options Transaction History

Antara Capital LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $2.37 Million - $4.36 Million	519,400 Added 34.63%	2,019,400 $12 Million
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $1.32 Million - $3.77 Million	354,000 Added 30.89%	1,500,000 $6.38 Million
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $9.5 Million - $22.2 Million	625,200 Added 120.05%	1,146,000 $21.8 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $2.63 Million - $4.89 Million	120,800 Added 30.2%	520,800 $17.3 Million
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $13 Million - $19.6 Million	400,000 New	400,000 $15.5 Million

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Antara Capital LP, based on Form 13F filings with the SEC.

Stay updated on Antara Capital LP with notifications on news.